Jan 10, 2022 / 02:00PM GMT
Cory William Kasimov - JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst
Great. Good morning, everyone, and once again, welcome to the 40th Annual and, unfortunately, second-time virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the Senior Large-Cap Biotech Analyst. And it's my pleasure to introduce our next company, Vertex Pharmaceuticals and CEO, Reshma Kewalramani.
Please note that following this presentation, we will have a Q&A session. (Operator Instructions) But with that, Reshma, thank you for being here today. Always a pleasure, and let me turn things over to you.
Reshma Kewalramani - Vertex Pharmaceuticals Incorporated - CEO, President & Director
Thanks, Cory. It's good to see you again, and thanks also to JPMorgan for hosting this event virtually today.
Good morning, all. I am pleased to be here and to share the significant progress we've made, and I'm really excited to share our vision for where Vertex is headed in 2022 and beyond. To keep us synchronized, I'll call out the slide
Vertex Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot